 |
Supplementary Information for: |
|
Identification of genes associated with chemotherapy cross-resistance and treatment response in childhood acute lymphoblastic leukemia.
Sanne Lugthart 1,2,6,8 , Meyling H. Cheok 1,2,8 , Monique L. den Boer 6 , Wenjian Yang 1,2,5 , Amy Holleman 6 , Cheng Cheng 3 , Ching-Hon Pui 1,4,5 , Mary V. Relling 1,2,5 , Gritta E. Janka-Schaub 7 , Rob Pieters 6,9 , William E. Evans 1,2,5,9
1 Hematological Malignancy Program
2 Department of Pharmaceutical Sciences
3 Department of Biostatistics
4 Department of Hematology-Oncology ,St. Jude Children's Research Hospital , Memphis , USA
5 The Pharmacogenetics of Anticancer Agents Research Group in the Pharmacogenetics Research Network, Memphis , Tennessee , USA
6 Department of Pediatric Oncology/Hematology ,Erasmus University Medical Center/Sophia Children's Hospital, ,Rotterdam , The Netherlands
7 COALL study group ,Children's University Hospital , Hamburg , Germany
8 These first authors contributed equally to this work.
9 These last authors contributed equally to this work.
|
|
|
Supplemental Table 5 : Genes discriminating VCR-ASP discordant resistance in pediatric B-lineage ALL.
Summary of the 200 gene probe sets discriminating VCR-ASP discordant resistance (139 genes, 13 cDNA clones) with corresponding Probe Set ID, gene name, gene symbol (GS), map location (ML) and ratio of expression in the unfavorable versus favorable group for VCR-ASP discordant resistance (Ratio). The ratio of expression calculated by the median log-transformed signal in VCR-sensitive plus ASP-resistant versus VCR-resistant plus ASP-sensitive (>1 is over-expressed in VCR-sensitive plus ASP-resistant ALL). A ratio of <1 represents an under-expressed probe sets in
VCR-sensitive plus ASP-resistance
patients. The 64 under-expressed probe sets in VCR-sensitive plus ASP-resistant samples had a median expression ratio of 0.55, and the 136 over-expressed probe sets had a median expression ratio of 1.32.
|
Probe Set ID |
Gene Name |
GS |
ML |
Ratio |
|
207645_s_at |
chromodomain helicase DNA binding protein 1-like |
CHD1L |
1q12 |
2.08 |
|
200772_x_at |
prothymosin, alpha (gene sequence 28) |
PTMA |
2q35-q36 |
1.37 |
|
211921_x_at |
prothymosin, alpha (gene sequence 28) |
PTMA |
2q35-q36 |
1.37 |
|
214097_at |
ribosomal protein S21 |
RPS21 |
20q13.3 |
1.42 |
|
211940_x_at |
H3 histone, family 3A |
H3F3A |
1q41 |
1.22 |
|
208755_x_at |
H3 histone, family 3A |
H3F3A |
1q41 |
1.26 |
|
213828_x_at |
H3 histone, family 3A |
H3F3A |
1q41 |
1.30 |
|
211445_x_at |
FKSG17 |
FKSG17 |
8q22.3 |
1.37 |
|
200094_s_at |
eukaryotic translation elongation factor 2 |
EEF2 |
19pter-q12 |
1.30 |
|
204102_s_at |
eukaryotic translation elongation factor 2 |
EEF2 |
19pter-q12 |
1.25 |
|
211937_at |
eukaryotic translation initiation factor 4B |
EIF4B |
12q13.13 |
1.50 |
|
201892_s_at |
IMP (inosine monophosphate) dehydrogenase 2 |
IMPDH2 |
3p21.2 |
1.81 |
|
210501_x_at |
eukaryotic translation initiation factor 3 subunit k |
eIF3k |
19q13.2 |
1.33 |
|
221494_x_at |
eukaryotic translation initiation factor 3 subunit k |
eIF3k |
19q13.2 |
1.35 |
|
211623_s_at |
fibrillarin |
FBL |
19q13.1 |
1.40 |
|
201216_at |
chromosome 12 open reading frame 8 |
C12orf8 |
12q24.13 |
1.59 |
|
213356_x_at |
heterogeneous nuclear ribonucleoprotein A1 |
HNRPA1 |
12q13.1 |
1.29 |
|
200016_x_at |
heterogeneous nuclear ribonucleoprotein A1 |
HNRPA1 |
12q13.1 |
1.29 |
|
200029_at |
ribosomal protein L19 |
RPL19 |
17q11.2-q12 |
1.27 |
|
200081_s_at |
CDNA clone IMAGE:6301163 |
unknown4 |
4q21.3 |
1.28 |
|
200651_at |
guanine nucleotide binding protein (G protein) |
GNB2L1 |
5q35.3 |
1.42 |
|
200936_at |
ribosomal protein L8 |
RPL8 |
8q24.3 |
1.35 |
|
213414_s_at |
ribosomal protein S19 |
RPS19 |
19q13.2 |
1.23 |
|
200010_at |
ribosomal protein L11 |
RPL11 |
1p36.1-p35 |
1.29 |
|
213080_x_at |
ribosomal protein L5 |
RPL5 |
1p22.1 |
1.37 |
|
200858_s_at |
ribosomal protein S8 |
RPS8 |
1p34.1-p32 |
1.25 |
|
200034_s_at |
ribosomal protein L6 |
RPL6 |
12q24.1 |
1.33 |
|
208635_x_at |
nascent-polypeptide-assoc. complex alpha polypeptide |
NACA |
12q23-q24.1 |
1.42 |
|
200735_x_at |
nascent-polypeptide-assoc. complex alpha polypeptide |
NACA |
12q23-q24.1 |
1.29 |
|
211939_x_at |
basic transcription factor 3 |
BTF3 |
5q13.3 |
1.30 |
|
208517_x_at |
basic transcription factor 3 |
BTF3 |
5q13.3 |
1.38 |
|
200005_at |
eukaryotic translation initiation factor 3, subunit 7 zeta |
EIF3S7 |
22q13.1 |
1.36 |
|
200036_s_at |
ribosomal protein L10a |
RPL10A |
6p21.3-p21.2 |
1.32 |
|
212042_x_at |
ribosomal protein L7 |
RPL7 |
8q13.3 |
1.34 |
|
200717_x_at |
ribosomal protein L7 |
RPL7 |
8q13.3 |
1.26 |
|
217740_x_at |
ribosomal protein L7a |
RPL7A |
9q34 |
1.32 |
|
200088_x_at |
ribosomal protein L12 |
RPL12 |
9q34 |
1.29 |
|
200809_x_at |
ribosomal protein L12 |
RPL12 |
9q34 |
1.22 |
|
214271_x_at |
ribosomal protein L12 |
RPL12 |
9q34 |
1.32 |
|
200715_x_at |
ribosomal protein L13a |
RPL13A |
19q13.3 |
1.58 |
|
201592_at |
eukaryotic translation initiation factor 3, subunit 3 gamma |
EIF3S3 |
8q24.11 |
1.53 |
|
200024_at |
ribosomal protein S5 |
RPS5 |
19q13.4 |
1.38 |
|
214167_s_at |
ribosomal protein, large, P0 |
RPLP0 |
12q24.2 |
1.57 |
|
211972_x_at |
ribosomal protein, large, P0 |
RPLP0 |
12q24.2 |
1.35 |
|
211720_x_at |
ribosomal protein, large, P0 |
RPLP0 |
12q24.2 |
1.40 |
|
201033_x_at |
ribosomal protein, large, P0 |
RPLP0 |
12q24.2 |
1.35 |
|
208856_x_at |
ribosomal protein, large, P0 |
RPLP0 |
12q24.2 |
1.35 |
|
208692_at |
ribosomal protein S3 |
RPS3 |
11q13.3-q13.5 |
1.28 |
|
211927_x_at |
eukaryotic translation elongation factor 1 gamma |
EEF1G |
11q12.3 |
1.27 |
|
200689_x_at |
eukaryotic translation elongation factor 1 gamma |
EEF1G |
11q12.3 |
1.35 |
|
211345_x_at |
eukaryotic translation elongation factor 1 gamma |
EEF1G |
11q12.3 |
1.32 |
|
213588_x_at |
ribosomal protein L14 |
RPL14 |
3p22-p21.2 |
1.44 |
|
200705_s_at |
eukaryotic translation elongation factor 1 beta 2 |
EEF1B2 |
2q33-q34 |
1.52 |
|
215963_x_at |
ribosomal protein L3 |
RPL3 |
22q13 |
1.57 |
|
201217_x_at |
ribosomal protein L3 |
RPL3 |
22q13 |
1.58 |
|
211666_x_at |
ribosomal protein L3 |
RPL3 |
22q13 |
1.54 |
|
211073_x_at |
ribosomal protein L3 |
RPL3 |
22q13 |
1.53 |
|
212039_x_at |
ribosomal protein L3 |
RPL3 |
22q13 |
1.50 |
|
200089_s_at |
ribosomal protein L4 |
RPL4 |
15q22 |
1.34 |
|
211710_x_at |
ribosomal protein L4 |
RPL4 |
15q22 |
1.47 |
|
201154_x_at |
ribosomal protein L4 |
RPL4 |
15q22 |
1.39 |
|
211542_x_at |
ribosomal protein S10, clone MGC:10943, mRNA |
unknown6 |
--- |
1.23 |
|
200817_x_at |
ribosomal protein S10 |
RPS10 |
6p21.31 |
1.30 |
|
213890_x_at |
ribosomal protein S16 |
RPS16 |
19q13.1 |
1.27 |
|
200781_s_at |
ribosomal protein S15a |
RPS15A |
16p |
1.27 |
|
200926_at |
ribosomal protein S23 |
RPS23 |
5q14.1 |
1.29 |
|
200909_s_at |
ribosomal protein, large P2 |
RPLP2 |
11p15.5-p15.4 |
1.45 |
|
208904_s_at |
ribosomal protein S28 |
RPS28 |
19p13.2 |
1.29 |
|
203034_s_at |
ribosomal protein L27a |
RPL27A |
11p15 |
1.31 |
|
201492_s_at |
ribosomal protein L41 |
RPL41 |
12q13 |
1.26 |
|
201429_s_at |
ribosomal protein L37a |
RPL37A |
2q35 |
1.24 |
|
208825_x_at |
ribosomal protein L23a |
RPL23A |
17q11 |
1.28 |
|
208834_x_at |
cadherin 1, type 1, E-cadherin (epithelial) |
CDH1 |
16q22.1 |
1.31 |
|
213377_x_at |
ribosomal protein S12 |
RPS12 |
6q23.1 |
1.30 |
|
201049_s_at |
ribosomal protein S18 |
RPS18 |
6p21.3 |
1.31 |
|
200963_x_at |
ribosomal protein L31 |
RPL31 |
2q12.1 |
1.29 |
|
200763_s_at |
ribosomal protein, large, P1 |
RPLP1 |
15q22 |
1.26 |
|
200061_s_at |
ribosomal protein S24 |
RPS24 |
10q22-q23 |
1.22 |
|
213583_x_at |
eukaryotic translation elongation factor 1 alpha 1 |
EEF1A1 |
6q14.1 |
1.17 |
|
204892_x_at |
eukaryotic translation elongation factor 1 alpha 1 |
EEF1A1 |
6q14.1 |
1.24 |
|
206559_x_at |
eukaryotic translation elongation factor 1 alpha 1 |
EEF1A1 |
6q14.1 |
1.25 |
|
213614_x_at |
eukaryotic translation elongation factor 1 alpha 1 |
EEF1A1 |
6q14.1 |
1.15 |
|
212433_x_at |
ribosomal protein S2 |
RPS2 |
16p13.3 |
1.27 |
|
210646_x_at |
ribosomal protein L13a |
RPL13A |
19q13.3 |
1.34 |
|
212790_x_at |
ribosomal protein L13a |
RPL13A |
19q13.3 |
1.35 |
|
221798_x_at |
ribosomal protein S2 |
RPS2 |
16p13.3 |
1.26 |
|
203107_x_at |
ribosomal protein S2 |
RPS2 |
16p13.3 |
1.17 |
|
211942_x_at |
ribosomal protein L13a |
RPL13A |
19q13.3 |
1.32 |
|
200031_s_at |
ribosomal protein S11 |
RPS11 |
19q13.3 |
1.24 |
|
200716_x_at |
ribosomal protein L13a |
RPL13A |
19q13.3 |
1.32 |
|
214042_s_at |
Similar to ribosomal protein L22 (LOC389175), mRNA |
unknown2 |
3q26.31 |
1.48 |
|
207132_x_at |
prefoldin 5 |
PFDN5 |
12q12 |
1.27 |
|
221700_s_at |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
UBA52 |
19p13.1-p12 |
1.21 |
|
200013_at |
MAM domain containing 2 |
MAMDC2 |
9q21.13-q21.2 |
1.29 |
|
214143_x_at |
ribosomal protein L24 |
RPL24 |
3q12 |
1.28 |
|
200082_s_at |
ribosomal protein S7 |
RPS7 |
2p25 |
1.21 |
|
213941_x_at |
ribosomal protein S7 |
RPS7 |
2p25 |
1.41 |
|
200012_x_at |
CDNA clone MGC:71781 IMAGE:5287560 |
unknown3 |
4q12 |
1.28 |
|
200091_s_at |
ribosomal protein S25 |
RPS25 |
11q23.3 |
1.22 |
|
221775_x_at |
ribosomal protein L22 |
RPL22 |
1p36.3-p36.2 |
1.28 |
|
208768_x_at |
ribosomal protein L22 |
RPL22 |
1p36.3-p36.2 |
1.29 |
|
213687_s_at |
ribosomal protein L35a |
RPL35A |
3q29-qter |
1.29 |
|
211487_x_at |
ribosomal protein S17, clone MGC:11144, mRNA |
unknown5 |
--- |
1.27 |
|
201665_x_at |
ribosomal protein S17 |
RPS17 |
15q |
1.21 |
|
200062_s_at |
ribosomal protein L30 |
RPL30 |
8q22 |
1.29 |
|
208645_s_at |
ribosomal protein S14 |
RPS14 |
5q31-q33 |
1.26 |
|
200018_at |
ribosomal protein S13 |
RPS13 |
11p15 |
1.30 |
|
200092_s_at |
ribosomal protein L37 |
RPL37 |
5p13 |
1.21 |
|
216380_x_at |
ribosomal protein S28 |
RPS28 |
19p13.2 |
1.26 |
|
217807_s_at |
glioma tumor suppressor candidate region gene 2 |
GLTSCR2 |
19q13.3 |
1.42 |
|
217747_s_at |
ribosomal protein S9 |
RPS9 |
19q13.4 |
1.33 |
|
214317_x_at |
ribosomal protein S9 |
RPS9 |
19q13.4 |
1.38 |
|
217313_at |
AC004692 PAC clone RP5-1107K12 from 7p12-p14 |
unknown1 |
--- |
1.24 |
|
200022_at |
ribosomal protein L18 |
RPL18 |
19q13 |
1.34 |
|
200003_s_at |
ribosomal protein L28 |
RPL28 |
19q13.4 |
1.35 |
|
200869_at |
ribosomal protein L18a |
RPL18A |
19p13 |
1.35 |
|
211475_s_at |
BCL2-associated athanogene |
BAG1 |
9p12 |
1.40 |
|
209087_x_at |
melanoma cell adhesion molecule |
MCAM |
11q23.3 |
1.98 |
|
210869_s_at |
melanoma cell adhesion molecule |
MCAM |
11q23.3 |
1.48 |
|
212481_s_at |
tropomyosin 4 |
TPM4 |
19p13.1 |
1.53 |
|
209604_s_at |
GATA binding protein 3 |
GATA3 |
10p15 |
2.74 |
|
209602_s_at |
GATA binding protein 3 |
GATA3 |
10p15 |
8.01 |
|
217787_s_at |
polypeptide UDP-N-acetylgalactosaminyltransferase 2 |
GALNT2 |
1q41-q42 |
2.30 |
|
204897_at |
prostaglandin E receptor 4 (subtype EP4) |
PTGER4 |
5p13.1 |
2.73 |
|
217523_at |
CD44 antigen (homing function and Indian blood group) |
CD44 |
11p13 |
2.33 |
|
212886_at |
DKFZP434C171 protein |
DKFZP434C171 |
5q33.1 |
1.85 |
|
205434_s_at |
AP2 associated kinase 1 |
AAK1 |
2p24.3-p14 |
1.45 |
|
220306_at |
FLJ20202 protein |
FLJ20202 |
1p12 |
1.84 |
|
60528_at |
phospholipase A2, group IVB (cytosolic) |
PLA2G4B |
15q11.2-q21.3 |
1.20 |
|
202315_s_at |
breakpoint cluster region |
BCR |
22q11.23 |
1.48 |
|
213897_s_at |
mitochondrial ribosomal protein L23 |
MRPL23 |
11p15.5-p15.4 |
1.70 |
|
201163_s_at |
insulin-like growth factor binding protein 7 |
IGFBP7 |
4q12 |
1.93 |
|
201403_s_at |
microsomal glutathione S-transferase 3 |
MGST3 |
1q23 |
1.51 |
|
217809_at |
basic leucine zipper and W2 domains 2 |
BZW2 |
7p21.2 |
1.52 |
|
211709_s_at |
stem cell growth factor; lymphocyte secreted C-type lectin |
SCGF |
19q13.3 |
3.20 |
|
205131_x_at |
stem cell growth factor; lymphocyte secreted C-type lectin |
SCGF |
19q13.3 |
3.73 |
|
209073_s_at |
numb homolog (Drosophila) |
NUMB |
14q24.3 |
0.71 |
|
209806_at |
histone 1, H2be |
HIST1H2BE |
6p21.3 |
0.58 |
|
215245_x_at |
fragile X mental retardation 1 |
FMR1 |
xq27.3 |
0.60 |
|
212476_at |
centaurin, beta 2 |
CENTB2 |
3q29 |
0.56 |
|
209004_s_at |
F-box and leucine-rich repeat protein 5 |
FBXL5 |
4p15.33 |
0.64 |
|
218951_s_at |
hypothetical protein FLJ11323 |
FLJ11323 |
xp22.33; yp11.32 |
0.60 |
|
206219_s_at |
vav 1 oncogene |
VAV1 |
19p13.2 |
0.74 |
|
219131_at |
transitional epithelia response protein |
TERE1 |
1pter |
0.65 |
|
212438_at |
putative nucleic acid binding protein RY-1 |
RY1 |
2p13.3 |
0.65 |
|
200709_at |
FK506 binding protein 1A, 12kDa |
FKBP1A |
20p13 |
0.72 |
|
203611_at |
telomeric repeat binding factor 2 |
TERF2 |
16q22.1 |
0.38 |
|
205267_at |
POU domain, class 2, associating factor 1 |
POU2AF1 |
11q23.1 |
0.39 |
|
213039_at |
rho/rac guanine nucleotide exchange factor (GEF) 18 |
ARHGEF18 |
19p13.3 |
0.57 |
|
39318_at |
T-cell leukemia/lymphoma 1A |
TCL1A |
14q32.1 |
0.46 |
|
209995_s_at |
T-cell leukemia/lymphoma 1A |
TCL1A |
14q32.1 |
0.42 |
|
208990_s_at |
heterogeneous nuclear ribonucleoprotein H3 (2H9) |
HNRPH3 |
10q22 |
|